|
ABOUT COMPANY
VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, is dedicated to developing and commercializing several drugs with the potential to treat anxiety, depression, and other central nervous system (CNS) disorders. The company is headquartered in South San Francisco, California.
|
EARNINGS
Gross Profit (TTM): 1089500
Market Capitalization: 389419000
Operating Margin (TTM): -21.85
PE Ratio: None
PEG Ratio: 0
Profit Margin: 0
Revenue Per Share (TTM): 0.01
Revenue (TTM): 1467600
Quarterly Earnings Growth YOY: 0
Quarterly Revenue Growth YOY: 0.072
Trailing PE: -
|
DIVIDENDS
Diluted EPS (TTM): -0.371
Dividend Date: None
Dividend Per Share: None
Dividend Yield: 0%
EBITDA: -26467900
ExDividend Date: None
Forward Annual Dividend Rate:
Forward Annual Dividend Yield:
|